Aspirin and other antiplatelet agents in the secondary and primary prevention of cardiovascular disease.

Aspirin and other antiplatelet agents in the secondary and primary prevention of cardiovascular disease.

Détails bibliographiques
Auteurs principaux:	Hennekens, C, Buring, J, Sandercock, P, Collins, R, Peto, R
Format:	Journal article
Langue:	English
Publié:	1989

Documents similaires

Aspirin and stroke.
par: Buring, J, et autres
Publié: (1990)

ASPIRIN USE AND CHRONIC DISEASES
par: Hennekens, C, et autres
Publié: (1990)

Aspirin in ischemic heart disease.
par: Hennekens, C, et autres
Publié: (1992)

Low-dose aspirin for migraine prophylaxis.
par: Buring, J, et autres
Publié: (1990)

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials.
par: Baigent, C, et autres
Publié: (2009)

Antioxidant vitamins, cancer, and cardiovascular disease - Reply
par: Hennekens, C, et autres
Publié: (1996)

Antiplatelet agents in stroke prevention.
par: Peto, R
Publié: (1988)

Aspirin in the primary prevention of vascular disease Reply
par: Baigent, C, et autres
Publié: (2009)

Aspirin in the primary prevention of vascular disease Reply
par: Baigent, C, et autres
Publié: (2009)

Prevention. Aspirin in primary prevention--good news and bad news.
par: Hennekens, C, et autres
Publié: (2012)

Prevention: Aspirin in primary prevention-good news and bad news
par: Hennekens, C, et autres
Publié: (2012)

Antiplatelet therapy for thromboprophylaxis: the need for careful consideration of the evidence from randomised trials. Antiplatelet Trialists' Collaboration.
par: Collins, R, et autres
Publié: (1994)

TRIALS OF ANTIPLATELET THERAPY - REPLY
par: Baigent, C, et autres
Publié: (1994)

Polypills with or without aspirin for primary prevention of cardiovascular disease
par: Mant, J, et autres
Publié: (2021)

Role of aspirin in primary prevention of cardiovascular disease
par: Patrono, C, et autres
Publié: (2019)

Aspirin overutilization for the primary prevention of cardiovascular disease
par: VanWormer JJ, et autres
Publié: (2014-12-01)

Aspirin for primary prevention of cardiovascular disease in diabetes
par: Ying Xing, et autres
Publié: (2019-07-01)

Underutilization of aspirin persists in US ambulatory care for the secondary and primary prevention of cardiovascular disease.
Publié: (2005-12-01)

Underutilization of aspirin persists in US ambulatory care for the secondary and primary prevention of cardiovascular disease.
par: Randall S Stafford, et autres
Publié: (2005-12-01)

Age and Aspirin Dosing in Secondary Prevention of Atherosclerotic Cardiovascular Disease
par: Guillaume Marquis‐Gravel, et autres
Publié: (2024-02-01)

An overview of the British and American aspirin studies.
par: Hennekens, C, et autres
Publié: (1988)

Sex-related differences in response to aspirin in cardiovascular disease: an untested hypothesis.
par: Hennekens, C, et autres
Publié: (2006)

PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE AND ANTIPLATELET THERAPY. CLINICAL LECTURE
par: L. O. Minushkina
Publié: (2017-12-01)

Which people should take aspirin for primary prevention of cardiovascular disease?
par: Lozano R, et autres
Publié: (2015-07-01)

Misuse of Aspirin and Associated Factors for the Primary Prevention of Cardiovascular Disease
par: Yinong Chen, et autres
Publié: (2021-09-01)

Use of aspirin for primary and secondary prevention of cardiovascular disease in diabetic patients in an ambulatory care setting in Spain
par: Fernández-de-Bobadilla Jaime, et autres
Publié: (2007-10-01)

Use and Misuse of Aspirin in Primary Cardiovascular Prevention
par: Sergio Coccheri
Publié: (2017-04-01)

Antiplatelet treatment in primary and secondary stroke prevention in women.
par: Caso, V, et autres
Publié: (2012)

Antiplatelet treatment in primary and secondary stroke prevention in women
par: Caso, V, et autres
Publié: (2012)

Low-dose aspirin for primary and secondary prevention of cardiovascular events in Denmark 1998–2018
par: Mikkel B. Christensen, et autres
Publié: (2021-06-01)

Primary prevention of cardiovascular events in diabetes: is there a role for aspirin?
par: Price, H, et autres
Publié: (2009)

Aspirin for prevention of cancer and cardiovascular disease.
par: Rose, P, et autres
Publié: (2011)

Antiplatelet therapy: aspirin for asymptomatic atherosclerosis?
par: Patrono, C, et autres
Publié: (2010)

Aspirin strategy for secondary prevention of atherosclerotic cardiovascular diseases: A narrative review
par: Nischal N Hegde, et autres
Publié: (2023-01-01)

Role of aspirin in the primary prevention of cardiovascular disease in patients with hyperlipoproteinaemia(a)
par: Eleni Giannopoulou, et autres
Publié: (2024-12-01)

US population qualifying for aspirin use for primary prevention of cardiovascular disease
par: Athena L. Huang, et autres
Publié: (2024-06-01)

US POPULATION QUALIFYING FOR ASPIRIN USE FOR PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE:
par: Athena L. Huang, MD, et autres
Publié: (2023-09-01)

DOCTOR’S ADHERENCE TO RECOMMENDATIONS GOVERNING THE ANTIPLATELET AGENTS USE IN THE CARDIOVASCULAR DISEASES PREVENTION AND TREATMENT
par: N. В. Perepech, et autres
Publié: (2018-05-01)

Antiplatelets in secondary stroke prevention
par: Olga eShulga, et autres
Publié: (2011-07-01)

Antioxidant vitamins--benefits not yet proved.
par: Hennekens, C, et autres
Publié: (1994)